Raisio updated the financial targets for its strategy period 2022-2025 in December 2022. Since then, the sharp change in consumer behaviour that occurred in 2023 has been reflected in Raisio's business as a halt in net sales growth. At the same time, Raisio's profitability, however, has improved significantly.

As visibility on market development continues to be low and consumer purchasing power is expected to remain weak also in 2024, Raisio updates its financial targets for the strategy period 2022-2025.

Raisio's updated financial targets for the strategy period 2022-2025

Raisio continues to systematically promote its strategic focus areas but abandons the growth and profitability targets, published in December 2022, for the period ending in 2025. Raisio still has confidence in the long-term growth potential of its key categories, but the growth is slower than expected in the short term due to challenging market conditions.

• the compound annual growth rate (CAGR) for the entire Raisio Group is 9% 
• the CAGR of the combined net sales of the three strategic focus areas (Benecol® and plant stanol ester solutions; value added oat products and ingredients; plant proteins) is 11%
• comparable EBIT of over 13% of the Group's net sales in 2025.
• With these targets, the net sales in the financial year 2025 will exceed EUR 280 million, while the comparable EBIT will be more than EUR 36 million.

Raisio will publish its net sales and EBIT for the year 2023, as well as guidance for 2024, on 13 February 2024 approximately at 8:30 am EET.

RAISIO PLC 

Board of Directors

Further information:

Pekka Kuusniemi, CEO, tel. +358 50 537 3883

Mika Saarinen, CFO, tel. +358 40 072 6808

RAISIO PLC

At Raisio, we make food from the heart, with the aim of bringing health to ourselves and the Earth. We keep creating better plant-based and heart-healthy products so that eating healthily and within the Earth's ecological capacity can be a pleasure. Our strong brands, such as Benecol®, Härkis® and Elovena®, turn our ambitions into reality. Through our responsibility work, we make the hard choices for consumers, so that they can choose Raisio products with confidence. We have around 350 healthy food colleagues in six countries and export to more than 40 markets around the world. Raisio's shares are listed on Nasdaq Helsinki Ltd. In 2022, the Group's comparable net sales for continuing operations were approximately EUR 221 million and the comparable EBIT was approximately EUR 18 million. www.raisio.com